29 January 2018 - Vaccination is the most powerful known measure for yellow fever prevention: a single dose can provide life-long immunity at a cost of approximately US$1. Ensuring adequate vaccine supply is available to reach all those at-risk is a constant challenge and the main purpose of the Eliminate Yellow Fever Epidemics (EYE) Strategy partnership, steered by WHO, UNICEF and Gavi, the Vaccine Alliance.
Brazil launches world’s largest campaign with fractional-dose yellow fever vaccine
25 January 2018 - Brazil has launched a mass immunization campaign that will deliver fractional doses of yellow fever vaccine to residents of 69 municipalities in the states of Rio de Janeiro and São Paulo. The strategic plan for the campaign was developed with support from the Pan American Health Organization (PAHO) and the World Health Organization (WHO). It will be the world’s largest vaccination campaign, to date, using fractional doses of yellow fever vaccine.
Nigeria set to vaccinate 25 million people, its biggest yellow fever campaign ever
24 January 2018 – The Government of Nigeria, with support from WHO and partners, will launch a mass vaccination campaign on 25 January 2018 to prevent the spread of yellow fever. More than 25 million people will be vaccinated throughout 2018, in the largest yellow fever vaccination drive in the country's history.
The immunization plan is part of efforts to eliminate yellow fever epidemics globally by 2026.
16 January 2018 - Since December 2016, Brazil is experiencing an upsurge of yellow fever virus activity. Considering the increased level of yellow fever virus activity observed across the state of São Paulo, the WHO Secretariat has determined that, in addition to the areas listed in previous updates, the entire state of São Paulo should also be considered at risk for yellow fever transmission. Consequently, vaccination against yellow fever is recommended for international travellers visiting any area in the state of São Paulo.
21 December 2017 - Reports of yellow fever cases throughout Nigeria are escalating concerns about the risk of large, costly, and difficult-to-control outbreaks in urban areas requiring huge supplies of life-saving vaccines and increasing the potential for large-scale national and worldwide spread. Fears that the situation in globally connected Nigeria could soon mirror the massive 2016 outbreak in Angola, during which cases were exported to neighboring DRC and as far as China, are raising urgent calls for quick containment.
The EYE Strategy addresses three important global health agendas
EYE is a global and comprehensive long-term strategy that aims at ending yellow fever epidemics by 2026. Areas of work encompass management of global vaccine supply including an emergency stockpile, and country implementation and engagement for improving surveillance and outbreak control.
The EYE strategy is committed to the main global health agendas: Universal Health Coverage, the International Health Regulations and Strengthening Health Systems.
African health ministers meeting in Victoria Falls, Zimbabwe, for the 67th Session of the WHO Regional Committee have agreed on ten priority actions to guide countries on the elimination of the yellow fever epidemics by 2026.
This endorsement reflects the strong political commitment of African nations to controlling yellow fever as a whole region.
- International Coordinating Group (ICG) on vaccine provision for yellow fever
Q&A: ICG on vaccine provision
- Q&A: Fractional doses of the yellow fever vaccine
Yellow fever vaccine supply in an emergency
Global vaccine stockpile in emergencies
- Yellow fever vaccine: a global partnership
Yellow fever vaccination booster not needed
- Yellow fever vaccine safety
Video: Yellow fever - facts and challenges
Yellow fever laboratory testing in Africa
Fractional dose yellow fever vaccine as a dose-sparing option for outbreak response
Communication and social mobilization in yellow fever mass vaccination campaigns
The Yellow Fever Initiative: providing an opportunity of a lifetime
Rapid ﬁeld entomological assessment during yellow fever outbreaks in Africa